CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) - 09/17/2026

Neutral
AI Analysis

Summary

FDA announcing a public meeting on September 17, 2026 to discuss the reauthorization of Generic Drug User Fee Amendments (GDUFA). The hybrid meeting will run from 9 a.m. to 2 p.m. ET.

Importance:2/10
Sentiment:
0.00
GDUFAgeneric_drugsFDApublic_meetingreauthorization

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 15, 2026 5:53 PM

Read Original